“…Most eukaryotic primary transcripts contain introns that have to be removed prior to their nucleocytoplasmic export to ensure translation of a continuous open reading frame (ORF)+ Splicing takes place in two catalytic steps within a large multicomponent complex, the spliceosome (for reviews, see Moore et al+, 1993;Burge et al+, 1998;Reed, 2000)+ One of the earliest steps in spliceosome assembly is the duplex formation between the free 59 end of the U1 snRNA and the 59 splice site+ The RNA duplex is not only stabilized through its hydrogen bonding but almost certainly through additional interactions of protein components with the pre-mRNA also in the vicinity of the 59 splice site (Puig et al+, 1999;Zhang & Rosbash, 1999;Del Gatto-Konczak et al+, 2000)+ Beside its role in the splicing reaction, the integrity of a 59 splice site is important for nuclear premRNA stability as has been shown by point mutations within the 59 splice site of, for example, the HIV-1 tat/ rev intron (Lu et al+, 1990) or polyoma virus late transcripts (Barrett et al+, 1995) leading to a decrease in the accumulation of unspliced transcripts+ Moreover, binding of snRNPs leads to nuclear retention of the RNA and it is generally recognized that completion of the splicing reaction removes this obstacle to RNA nucleocytoplasmic export (Chang & Sharp, 1989;Legrain & Rosbash, 1989;Hamm & Mattaj, 1990;Huang & Carmichael, 1996)+ There remains a conceptual problem of how the nucleocytoplasmic export of unspliced RNA equipped with suitable snRNP binding sites occurs+ This is the case for the nucleocytoplasmic export of a variety of retroand pararetrovirus mRNAs (Cullen, 1992;Kiss-Laszlo & Hohn, 1996;Bodem et al+, 1997)+ The overlapping of their genes entails that one and the same sequence may be part of an intron or of an exon, depending on which gene is being expressed+ To enable the use of their full genomic potential, the excision of introns has to be restrained by regulatory processes, for instance, through inefficient 39 splice sites (Katz & Skalka, 1990;Fu et al+, 1991;McNally & Beemon, 1992;Staffa & Cochrane, 1994;Dyhr-Mikkelsen & Kjems, 1995;O'Reilly et al+, 1995;Zhang & Stoltzfus, 1995;Si et al+, 1997) or cis-acting splicing enhance...…”